av/faron-pharmaceuticals-oy--big.svg

COM:FARON

Faron Pharmaceuticals Ltd.

  • Stock

GBP

Last Close

142.50

22/11 14:00

Market Cap

1.36M

Beta: -

Volume Today

20.05K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-1.51M
-
-1.36M
9.55%
-6.14M
350.44%
-9.29M
51.27%
-21.06M
126.60%
-20.08M
4.63%
-13.25M
34.02%
-16.94M
27.81%
-21.19M
25.14%
-28.73M
35.56%
-30.94M
7.71%
depreciation and amortization
56K
-
60K
7.14%
184K
206.67%
168K
8.70%
76K
54.76%
100K
31.58%
238K
138%
283K
18.91%
307K
8.48%
300K
2.28%
346K
15.33%
deferred income tax
-285K
-
-360K
26.32%
279K
177.50%
-65K
123.30%
-56K
13.85%
98K
275%
114K
16.33%
-1.25M
-
stock based compensation
430K
-
480K
11.63%
1.19M
147.71%
-176K
114.80%
51K
128.98%
386K
656.86%
1.49M
285.23%
1.30M
12.78%
2.45M
88.90%
change in working capital
694K
-
916K
31.99%
-1.71M
286.35%
193K
111.31%
1.08M
458.55%
-421K
139.05%
1.34M
417.58%
-872K
165.22%
-1.76M
101.95%
4.77M
370.64%
3.24M
31.93%
accounts receivables
inventory
-553K
-
400K
172.33%
50K
87.50%
-802K
1,704%
accounts payables
other working capital
1.25M
-
516K
58.62%
-1.76M
440.50%
995K
156.63%
other non cash items
-10K
-
-1K
90%
376K
37,700%
361K
3.99%
75K
79.22%
121K
61.33%
158K
30.58%
-438K
377.22%
-1.17M
167.35%
-626K
46.54%
1.10M
275.40%
net cash provided by operating activities
-768K
-
-389K
49.35%
-7.15M
1,737.02%
-8.45M
18.28%
-18.36M
117.26%
-20.52M
11.77%
-11.52M
43.86%
-17.48M
51.69%
-22.22M
27.11%
-22.99M
3.49%
-23.81M
3.54%
investments in property plant and equipment
-73K
-
-151K
106.85%
-107K
29.14%
-92K
14.02%
-98K
6.52%
-295K
201.02%
-100K
66.10%
-142K
42%
-474K
233.80%
-385K
18.78%
-123K
68.05%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
1K
-
net cash used for investing activites
-73K
-
-151K
106.85%
-107K
29.14%
-92K
14.02%
-98K
6.52%
-295K
201.02%
-100K
66.10%
-142K
42%
-473K
233.10%
-385K
18.60%
-123K
68.05%
debt repayment
-434K
-
-343K
20.97%
-151K
-
-84K
44.37%
-347K
313.10%
-151
99.96%
-122K
80,694.70%
-122K
0%
-105K
13.93%
-861K
720%
common stock issued
1.27M
-
1.13M
11.76%
18.08M
1,507.11%
8.52M
52.88%
17.36M
103.80%
17.02M
1.95%
15.63M
8.20%
14.10M
9.75%
25.56M
81.23%
13.45M
47.40%
26.03M
93.61%
common stock repurchased
dividends paid
other financing activites
587K
-
-695K
218.40%
-1.14M
63.31%
-1.02M
10.23%
806K
179.11%
153K
81.02%
10.14M
6,526.14%
81K
99.20%
net cash used provided by financing activities
841K
-
782K
7.02%
18.08M
2,212.02%
8.96M
50.47%
16.58M
85.18%
15.54M
6.28%
14.61M
6.00%
14.79M
1.23%
25.59M
73.06%
23.48M
8.25%
23.98M
2.15%
effect of forex changes on cash
-1K
-
-1K
0%
-290K
28,900%
36K
112.41%
7K
80.56%
-117K
1,771.43%
-153K
30.77%
37K
124.18%
-168K
554.05%
net change in cash
242K
-
10.83M
4,373.55%
410K
96.21%
-2.17M
628.78%
-5.24M
141.84%
2.99M
157.07%
-2.95M
198.63%
2.75M
193.02%
137K
95.01%
-114K
183.21%
cash at beginning of period
242K
-
11.07M
4,473.55%
11.48M
3.70%
9.31M
18.89%
4.07M
56.32%
7.06M
73.57%
4.11M
41.80%
6.85M
66.82%
6.99M
2.00%
cash at end of period
242K
-
11.07M
4,473.55%
11.48M
3.70%
9.31M
18.89%
4.07M
56.32%
7.06M
73.57%
4.11M
41.80%
6.85M
66.82%
6.99M
2.00%
6.88M
1.63%
operating cash flow
-768K
-
-389K
49.35%
-7.15M
1,737.02%
-8.45M
18.28%
-18.36M
117.26%
-20.52M
11.77%
-11.52M
43.86%
-17.48M
51.69%
-22.22M
27.11%
-22.99M
3.49%
-23.81M
3.54%
capital expenditure
-73K
-
-151K
106.85%
-107K
29.14%
-92K
14.02%
-98K
6.52%
-295K
201.02%
-100K
66.10%
-142K
42%
-474K
233.80%
-385K
18.78%
-123K
68.05%
free cash flow
-841K
-
-540K
35.79%
-7.25M
1,243.15%
-8.54M
17.80%
-18.46M
116.07%
-20.82M
12.78%
-11.62M
44.17%
-17.62M
51.60%
-22.69M
28.78%
-23.38M
3.02%
-23.93M
2.36%

All numbers in GBP (except ratios and percentages)